Screener
OrthoPediatrics KIDS EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from OrthoPediatrics’s reported figures.
The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 1:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001425450-26-000070
FAQ
- What is OrthoPediatrics's EBITDA?
- OrthoPediatrics (KIDS) reported EBITDA of $1.64M in Q2 2026.
- How has OrthoPediatrics's EBITDA changed year-over-year?
- OrthoPediatrics's EBITDA increased by 129.9% year-over-year, from -$5.49M to $1.64M.
- What is the long-term trend for OrthoPediatrics's EBITDA?
- Over 4 years (2021 to 2025), OrthoPediatrics's EBITDA has grown at a 25.3% compound annual growth rate (CAGR), from -$7.34M to -$18.12M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about OrthoPediatrics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude